Carol Gregorio

8PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Gene and molecular therapyLiquid biopsiesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 24, 2025
Prediction and biological significance of small changes in binding of leiomodin to tropomyosin.

Eduardo Sánchez Díaz, Brayan Osegueda, Svetlana Minakhina

|Sep 16, 2024
Leiomodin 2 neonatal dilated cardiomyopathy mutation results in altered actin gene signatures and cardiomyocyte dysfunction.

Jessika B Iwanski, Christopher T Pappas, Rachel M Mayfield

|May 15, 2024
Human disease-causing mutations result in loss of leiomodin 2 through nonsense-mediated mRNA decay.

Christopher T Pappas, Rachel M Mayfield, Ava E Dickerson

|Mar 13, 2024
Lmod2 is necessary for effective skeletal muscle contraction.

Tania M Larrinaga, Gerrie P Farman, Rachel M Mayfield

|Jan 03, 2024
Recessive TMOD1 mutation causes childhood cardiomyopathy.

Catalina Vasilescu, Mert Colpan, Tiina H Ojala

|Mar 20, 2021
CAP2 is a regulator of actin pointed end dynamics and myofibrillogenesis in cardiac muscle.

Mert Colpan, Jessika Iwanski, Carol C Gregorio

Pageof 2